(lp0
S'What is the Street Saying About Catalyst Pharmaceutical Partners, Inc. (NASDAQ ... Aiken Advocate - May 17, 2016 Investors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Catalyst Pharmaceutical Partners,&nbsp;...'
p1
aS'Catalyst Pharma shares jump 22% premarket on news of positive trial results ... MarketWatch - 20 hours ago Shares of Catalyst Pharmaceuticals Inc. CPRX, +32.48% jumped 22% in premarket trade Wednesday, after the biotech reported positive data from a trial of a treatment for a form of myasthenia gravis, a rare neuromuscular disease, for which there is ...Catalyst Pharma positive trial data of a treatment for a rare neuromuscular ... - Proactive Investors USA & CanadaCATALYST PHARMACEUTICALS, INC.  Files An 8-K Other Events - Market Exclusive'
p2
aS'Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2016 Financial ... GlobeNewswire  - 12 hours ago CORAL GABLES, Fla., March 15, 2017  -- Catalyst Pharmaceuticals, Inc.  , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular&nbsp;...'
p3
aS'BUZZ-US STOCKS ON THE MOVE-Catalyst Pharma, Magicjack, Rubicon Project Nasdaq - 16 hours ago CATALYST PHARMACEUTICALS INC &lt;CPRX.O&gt;, $1.61, +37.29 pct The company said its experimental drug to treat patients with a severe form of myasthenia gravis, a rare neuromuscular disease, met the main goals of a study.US STOCKS ON THE MOVE-Catalyst Pharma, MSCI, Rubicon Project - Times of India'
p4
aS"Noteworthy Stock: Catalyst Pharmaceuticals, Inc.  Is stories - 2 hours ago Catalyst Pharmaceuticals, Inc.'s  witnessed a gain of 32.48% in recent trading period with closing price of $ 1.55."
p5
aS'Catalyst Pharmaceuticals to Present at the 29th Annual ROTH Conference GlobeNewswire  - Mar 9, 2017 CORAL GABLES, Fla., March 10, 2017  -- Catalyst Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today&nbsp;...'
p6
aS'Catalyst Pharmaceuticals Announces Positive Data from Investigator-Sponsored ... GlobeNewswire  - 21 hours ago CORAL GABLES, Fla., March 15, 2017  -- Catalyst Pharmaceuticals, Inc.  , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular&nbsp;...'
p7
aS'Catalyst Pharma : What???s in Store in Q4 Earnings? Yahoo Finance - Mar 7, 2017 Catalyst Pharmaceuticals, Inc. CPRX is expected to report fourth-quarter 2016 results this month. Last quarter, the company recorded a positive earnings surprise of 16.67%.Catalyst Pharmaceutical Partners, Inc.  Broker Price Targets For The ... - Fiscal Standard'
p8
aS'Broadfin Capital is Buying Catalyst Pharmaceuticals Inc.  Shares Small Cap Exclusive  - Feb 13, 2017 In a just published Form 13, filed with the US Securities and Exchange Commission , Catalyst Pharmaceuticals Inc.  reported that Broadfin Capital has picked up 8,200,000 of common stock as of 2017-02-13.'
p9
aS"Sell-Side Analyst's Predictions: Prospect Capital Corporation , Catalyst ... The USA Commerce - 20 hours ago Shares of Prospect Capital Corporation  dropped -0.33% to $9.09. During the trading on 03/14/2017, Company's stock ranged from $9.09 to $9.22. The relative strength index or RSI highlights overbought  and oversold &nbsp;..."
p10
a.